#PlaybyPlay: #SuperBowl Champion Junior Bryant, Who Lived in Severe Pain After a Career-Ending Neck Injury, Endorses Phytoceutical Medicine from the Peak Health Center
Point Roberts, WA and Delta, BC - November 5, 2018 (Investorideas.com Newswire) Investorideas.com, a leader in investor news and research issues today's edition of Play by Play covering what's new in sports headlines and recent news from publicly traded companies in the sector.
Listen to the podcast:
#PlaybyPlay: #SuperBowl Champion Junior Bryant Endorses Phytoceutical Medicine from the Peak Health Center
Play by Play - the latest sports headlines, esports and sports stock news
Super Bowl Champion Junior Bryant, Who Lived in Severe Pain After a Career-Ending Neck Injury, Endorses Phytoceutical Medicine from the Peak Health Center
"It's important for me to spread the message of healing using all-natural, plant-based products. I have never been one to take pharmaceuticals, but I was forced to because the pain I was living in was unbearable -- until I found Peak Health Center." - Junior Bryant
Junior Bryant played six seasons for the San Francisco 49ers as a defensive lineman before he suffered a career-ending neck injury in 2000 during a game in St. Louis. Bryant, just 29 years old at the time, subsequently found living with the injury very challenging as there was no surgical solution and conventional meds were ineffective.
"Physically it was difficult because of the nature of my injury," he said. "We couldn't do surgery so there was nothing to really fix. When it came time to take pain pills and try to mitigate some of the injuries...it was harder to manage that. I just had to kind of deal with it because I wasn't really getting the benefit."
Bryant's experience changed, however, when he met Dr. Bomi Joseph, FDA health advisor and founder of California-based nutrition and fitness company Peak Health.
"I was introduced to Dr. Joseph through a friend and met with him," Bryant said. "I think our first meeting was about four or five hours. It was just fascinating."
Peak Health develops phytoceutical (medicine derived from plants or herbs) products distributed through the Phyto Farmacy. This includes the recently patented ImmunAG™, the first non-cannabis cannabidiol (CBD) derived medicine from the Kriya Humulus plant. Bryant has been taking the product since first being introduced to Dr. Joseph and Peak Health.
"I started using ImmunAG™ the first day when I met Dr. Joseph and I've been on it ever since," he said.
Bryant's former teammate from the 49ers, Bart Oates, who also suffered a career-ending injury, advocates Cannabinoid derived treatment for concussions, as he told Investorideas.com last year. Dr. Bomi Joseph commented on why athletes may be more receptive to new and different types of medicine.
"I love working with elite athletes for one simple reason: They're much more in tune," Dr. Joseph said. "Their mind-body connection is so far greater than a normal person. Even injured athletes or athletes [who are] out of shape...they're very much in tune with their body."
Sam Mowers, Investorideas.com
Sports Stocks - esports, sports media, sports teams, sports betting, fantasy sports, sports equipment and more...
Like Sports Stocks? View our Sports Stocks Directory Get News Alerts on Sports Stocks
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts, articles, podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Learn more about Investor ideas podcast and news publication services and costs https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Copyright and ownership: Play by Play is an Investorideas.com content brand
To contribute interviews, story ideas and find out more about sponsorship opportunities:
Follow us on Social Media
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment